首页> Neurology> Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

导出 LinkOut

翻译打印收藏纠错

第一作者： Didier,Leys

第一单位： From Degenerative & Vascular Cognitive Disorders (D.L., C.J., S.M., C.C., T.O., A.-M.M., C.P., H.H., N.D.-P., M.B., C.R., R.B.), Department of Neurology, INSERM U 1171, CHU Lille, Universite Lille; Strokavenir Network (D.L., Y.H., C.J., S.M., I.S., J.-L.M., T.M., M.G., S.S., C.C., E.M.d.B., G.T., T.R., Y.B., O.D., T.O., A.-M.M., P.F., M.Z., A.T.-B., O.O.-W., F.M.M., C.L., A.F., L.L., C.P., M.P., H.H., P.R., N.D.-P., M.B., S.D., C.R., R.B., D.V.), Lille; Inserm UMR-S 919 (Y.H., L.L., D.V.), University Caen-Normandie, GIP Cyceron, Caen; Bordeaux University Hospital (I.S., S.S., M.P., P.R., S.D.), University of Bordeaux; INSERM UMR S894 (J.-L.M., G.T.), Sainte-Anne Hospital, DHU NeuroVasc, Sorbonne Paris Cité, University Paris Descartes; Besançon University Hospital (T.M., E.M.d.B.), University of Franche-Comté; Dijon Stroke Registry (INSERM and INVS) (M.G., Y.B.), Dijon University Hospital, University of Burgundi; University of Rennes (T.R.); University Grenoble Alpes (O.D.); University Hospital Paris Tenon (P.F.); Sorbonne Paris Citéitbonne, University Hospital Paris St Joseph, University Paris Descartes; Rouen University Hospital (A.T.-B., O.O.-W.); University Hospital of Limoges (F.M.M.); Amiens University Hospital (C.L.); and Ste.-Anne Military Teaching Hospital (A.F.), Toulon, France. didier.leys@univ-lille2.fr.

作者： Didier,Leys ^[1] ; Yannick,Hommet ^[2] ; Clémence,Jacquet ^[2] ; Solène,Moulin ^[2] ; Igor,Sibon ^[2] ; Jean-Louis,Mas ^[2] ; Thierry,Moulin ^[2] ; Maurice,Giroud ^[2] ; Sharmila,Sagnier ^[2] ; Charlotte,Cordonnier ^[2] ; Elisabeth,Medeiros de Bustos ^[2] ; Guillaume,Turc ^[2] ; Thomas,Ronzière ^[2] ; Yannick,Bejot ^[2] ; Olivier,Detante ^[2] ; Thavarak,Ouk ^[2] ; Anne-Marie,Mendyk ^[2] ; Pascal,Favrole ^[2] ; Mathieu,Zuber ^[2] ; Aude,Triquenot-Bagan ^[2] ; Ozlem,Ozkul-Wermester ^[2] ; Francisco Macian,Montoro ^[2] ; Chantal,Lamy ^[2] ; Anthony,Faivre ^[2] ; Laurent,Lebouvier ^[2] ; Camille,Potey ^[2] ; Mathilde,Poli ^[2] ; Hilde,Hénon ^[2] ; Pauline,Renou ^[2] ; Nelly,Dequatre-Ponchelle ^[2] ; Marie,Bodenant ^[2] ; Sabrina,Debruxelles ^[2] ; Costanza,Rossi ^[2] ; Régis,Bordet ^[2] ; Denis,Vivien ^[2] ; OPHELIE investigators and the STROKAVENIR network

作者单位： From Degenerative & Vascular Cognitive Disorders (D.L., C.J., S.M., C.C., T.O., A.-M.M., C.P., H.H., N.D.-P., M.B., C.R., R.B.), Department of Neurology, INSERM U 1171, CHU Lille, Universite Lille; Strokavenir Network (D.L., Y.H., C.J., S.M., I.S., J.-L.M., T.M., M.G., S.S., C.C., E.M.d.B., G.T., T.R., Y.B., O.D., T.O., A.-M.M., P.F., M.Z., A.T.-B., O.O.-W., F.M.M., C.L., A.F., L.L., C.P., M.P., H.H., P.R., N.D.-P., M.B., S.D., C.R., R.B., D.V.), Lille; Inserm UMR-S 919 (Y.H., L.L., D.V.), University Caen-Normandie, GIP Cyceron, Caen; Bordeaux University Hospital (I.S., S.S., M.P., P.R., S.D.), University of Bordeaux; INSERM UMR S894 (J.-L.M., G.T.), Sainte-Anne Hospital, DHU NeuroVasc, Sorbonne Paris Cité, University Paris Descartes; Besançon University Hospital (T.M., E.M.d.B.), University of Franche-Comté; Dijon Stroke Registry (INSERM and INVS) (M.G., Y.B.), Dijon University Hospital, University of Burgundi; University of Rennes (T.R.); University Grenoble Alpes (O.D.); University Hospital Paris Tenon (P.F.); Sorbonne Paris Citéitbonne, University Hospital Paris St Joseph, University Paris Descartes; Rouen University Hospital (A.T.-B., O.O.-W.); University Hospital of Limoges (F.M.M.); Amiens University Hospital (C.L.); and Ste.-Anne Military Teaching Hospital (A.F.), Toulon, France. didier.leys@univ-lille2.fr. ^[1] From Degenerative & Vascular Cognitive Disorders (D.L., C.J., S.M., C.C., T.O., A.-M.M., C.P., H.H., N.D.-P., M.B., C.R., R.B.), Department of Neurology, INSERM U 1171, CHU Lille, Universite Lille; Strokavenir Network (D.L., Y.H., C.J., S.M., I.S., J.-L.M., T.M., M.G., S.S., C.C., E.M.d.B., G.T., T.R., Y.B., O.D., T.O., A.-M.M., P.F., M.Z., A.T.-B., O.O.-W., F.M.M., C.L., A.F., L.L., C.P., M.P., H.H., P.R., N.D.-P., M.B., S.D., C.R., R.B., D.V.), Lille; Inserm UMR-S 919 (Y.H., L.L., D.V.), University Caen-Normandie, GIP Cyceron, Caen; Bordeaux University Hospital (I.S., S.S., M.P., P.R., S.D.), University of Bordeaux; INSERM UMR S894 (J.-L.M., G.T.), Sainte-Anne Hospital, DHU NeuroVasc, Sorbonne Paris Cité, University Paris Descartes; Besançon University Hospital (T.M., E.M.d.B.), University of Franche-Comté; Dijon Stroke Registry (INSERM and INVS) (M.G., Y.B.), Dijon University Hospital, University of Burgundi; University of Rennes (T.R.); University Grenoble Alpes (O.D.); University Hospital Paris Tenon (P.F.); Sorbonne Paris Citéitbonne, University Hospital Paris St Joseph, University Paris Descartes; Rouen University Hospital (A.T.-B., O.O.-W.); University Hospital of Limoges (F.M.M.); Amiens University Hospital (C.L.); and Ste.-Anne Military Teaching Hospital (A.F.), Toulon, France. ^[2]